Alembic Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and seventy-two approved drugs.
There are eleven tentative approvals on ALEMBIC drugs.
Summary for Alembic
US Patents: | 0 |
Tradenames: | 134 |
Ingredients: | 133 |
NDAs: | 172 |
Patent Litigation for Alembic: | See patent lawsuits for Alembic |
PTAB Cases with Alembic as petitioner: | See PTAB cases with Alembic as petitioner |
Drugs and US Patents for Alembic
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | ACETAZOLAMIDE | acetazolamide | CAPSULE, EXTENDED RELEASE;ORAL | 210423-001 | Feb 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alembic | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 203390-003 | Oct 28, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Alembic Global | TREPROSTINIL | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 211574-004 | Feb 11, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alembic | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 204891-001 | Jan 11, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alembic | METRONIDAZOLE | metronidazole | CAPSULE;ORAL | 079065-001 | Jun 23, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alembic | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 216262-001 | Aug 26, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.